Article Versions Notes

Penco-Campillo M, Molina C, Piris P, Soufi N, Carré M, Pagnuzzi-Boncompagni M, Picco V, Dufies M, Ronco C, Benhida R, et al. Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas. Cells. 2022; 11(23):3933. https://doi.org/10.3390/cells11233933

Penco-Campillo, Manon, Clément Molina, Patricia Piris, Nouha Soufi, Manon Carré, Marina Pagnuzzi-Boncompagni, Vincent Picco, Maeva Dufies, Cyril Ronco, Rachid Benhida, and et al. 2022. "Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas" Cells 11, no. 23: 3933. https://doi.org/10.3390/cells11233933

Penco-Campillo, M., Molina, C., Piris, P., Soufi, N., Carré, M., Pagnuzzi-Boncompagni, M., Picco, V., Dufies, M., Ronco, C., Benhida, R., Martial, S., & Pagès, G. (2022). Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas. Cells, 11(23), 3933. https://doi.org/10.3390/cells11233933